Trial intelligence / Profile preview

Low-dose versus high-dose propofol during anesthesia induction with remifentanil

2019-000958-56Phase 4Completed

Sponsor
Helse Fonna
Start
Mar 2019
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of propofol and remifentanil in Perioperative cardiovascular instability (PCVI) (2 arms), sponsored by Helse Fonna. Primary endpoints: Relative change in systolic blood pressure, Relative change in heart rate and 1 more. Started Mar 2019; status: completed.

02

Drugs

propofolremifentanil
03

Conditions

Perioperative cardiovascular instability (PCVI)

Beyond the preview

Go deeper on 2019-000958-56.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2019-000958-56.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call